Influit Energy

Litholink, situated in Itasca, IL, stands as a renowned facility specializing in kidney stone prevention. Providing advanced diagnostic testing services, Litholink utilizes cutting-edge technology to analyze patients' urine samples. Through their precision and expertise, they offer valuable insights to both healthcare providers and individuals seeking proactive kidney health solutions. With a strong focus on research and innovation, Litholink plays a crucial role in advancing kidney stone treatment strategies. Their commitment to excellence in clinical diagnostics is evident in the meticulous analysis they conduct, empowering healthcare professionals to make informed decisions for optimal patient care. By combining scientific rigor with personalized care, Litholink continues to make significant contributions to the field of kidney stone prevention. Generated using this brand's available information

SELAGINE Inc. is a Chicago-based company that has emerged as a spin-out from the University of Illinois at Chicago, dedicated to developing innovative therapeutics. The company focuses on addressing ocular surface diseases that arise from various inflammatory, immunological, and infectious causes. With a commitment to improving patient outcomes, SELAGINE Inc. is at the forefront of therapeutic advancements targeting eye health. Their research and development efforts aim to meet the needs of individuals suffering from complex ocular conditions. Generated from the website

Clarix Imaging, headquartered in Chicago, IL, specializes in advanced imaging technologies for breast surgical oncology, notably through its VSI-360 Intraoperative Volumetric Specimen Imaging System. This innovative system enables surgeons to visualize lumpectomy specimen margins in true 3D clarity, significantly enhancing the accuracy of surgical pathology assessments. With a strong foundation in decades of NIH-funded research, Clarix Imaging seeks to translate scientific advancements into clinical practice, providing tools that improve patient care. The VSI-360 has demonstrated improved sensitivity and specificity in clinical trials, making it a crucial asset for surgical teams dedicated to breast cancer treatment. Generated from the website